1. Home
  2. BIVI vs XHLD Comparison

BIVI vs XHLD Comparison

Compare BIVI & XHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • XHLD
  • Stock Information
  • Founded
  • BIVI 2013
  • XHLD 2011
  • Country
  • BIVI United States
  • XHLD United States
  • Employees
  • BIVI N/A
  • XHLD N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • XHLD
  • Sector
  • BIVI Health Care
  • XHLD
  • Exchange
  • BIVI Nasdaq
  • XHLD NYSE
  • Market Cap
  • BIVI 18.6M
  • XHLD 17.6M
  • IPO Year
  • BIVI N/A
  • XHLD 2025
  • Fundamental
  • Price
  • BIVI $0.97
  • XHLD $0.39
  • Analyst Decision
  • BIVI
  • XHLD Strong Buy
  • Analyst Count
  • BIVI 0
  • XHLD 1
  • Target Price
  • BIVI N/A
  • XHLD $8.00
  • AVG Volume (30 Days)
  • BIVI 210.2K
  • XHLD 1.2M
  • Earning Date
  • BIVI 05-12-2025
  • XHLD 08-20-2025
  • Dividend Yield
  • BIVI N/A
  • XHLD N/A
  • EPS Growth
  • BIVI N/A
  • XHLD N/A
  • EPS
  • BIVI N/A
  • XHLD N/A
  • Revenue
  • BIVI N/A
  • XHLD $3,115,000.00
  • Revenue This Year
  • BIVI N/A
  • XHLD $42.64
  • Revenue Next Year
  • BIVI N/A
  • XHLD $65.31
  • P/E Ratio
  • BIVI N/A
  • XHLD N/A
  • Revenue Growth
  • BIVI N/A
  • XHLD N/A
  • 52 Week Low
  • BIVI $0.62
  • XHLD $0.33
  • 52 Week High
  • BIVI $7.50
  • XHLD $8.54
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 42.25
  • XHLD N/A
  • Support Level
  • BIVI $0.88
  • XHLD N/A
  • Resistance Level
  • BIVI $1.03
  • XHLD N/A
  • Average True Range (ATR)
  • BIVI 0.07
  • XHLD 0.00
  • MACD
  • BIVI -0.02
  • XHLD 0.00
  • Stochastic Oscillator
  • BIVI 23.97
  • XHLD 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About XHLD TEN HOLDINGS INC

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. The company produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events.

Share on Social Networks: